 Michael Yeager
Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 22 | 2021 | 1884 | 2.290 |
Why?
| | Down Syndrome | 6 | 2024 | 455 | 2.020 |
Why?
| | Respiratory Tract Infections | 2 | 2024 | 373 | 1.280 |
Why?
| | Pulmonary Artery | 7 | 2021 | 1093 | 0.810 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 2 | 2021 | 17 | 0.760 |
Why?
| | Matrix Metalloproteinases | 2 | 2021 | 90 | 0.760 |
Why?
| | Ventricular Function | 1 | 2021 | 62 | 0.730 |
Why?
| | Fibroblasts | 6 | 2013 | 946 | 0.570 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2017 | 62 | 0.520 |
Why?
| | Vascular Stiffness | 1 | 2021 | 480 | 0.500 |
Why?
| | Blood Vessels | 2 | 2013 | 184 | 0.480 |
Why?
| | Biomarkers | 2 | 2015 | 3893 | 0.440 |
Why?
| | Lymphoid Tissue | 1 | 2013 | 68 | 0.430 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2012 | 431 | 0.410 |
Why?
| | Lung | 6 | 2023 | 3928 | 0.380 |
Why?
| | Arteritis | 1 | 2012 | 27 | 0.380 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 48 | 0.380 |
Why?
| | Proteomics | 2 | 2015 | 988 | 0.370 |
Why?
| | Precision Medicine | 1 | 2015 | 385 | 0.360 |
Why?
| | Mesoderm | 2 | 2011 | 139 | 0.360 |
Why?
| | Phagocytes | 1 | 2011 | 96 | 0.350 |
Why?
| | Microsatellite Repeats | 2 | 2002 | 163 | 0.350 |
Why?
| | Proteome | 1 | 2015 | 426 | 0.350 |
Why?
| | Blood Proteins | 1 | 2012 | 233 | 0.350 |
Why?
| | Myeloid Cells | 1 | 2011 | 141 | 0.340 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 229 | 0.340 |
Why?
| | Lung Diseases | 1 | 2017 | 757 | 0.340 |
Why?
| | Endothelin-1 | 1 | 2012 | 179 | 0.340 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2012 | 247 | 0.330 |
Why?
| | Immunoglobulin G | 1 | 2013 | 842 | 0.320 |
Why?
| | Endothelium, Vascular | 3 | 2002 | 920 | 0.260 |
Why?
| | Autoantibodies | 1 | 2013 | 1463 | 0.250 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 2022 | 0.230 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2002 | 55 | 0.230 |
Why?
| | Cytokines | 4 | 2017 | 2008 | 0.220 |
Why?
| | Child | 7 | 2024 | 20963 | 0.220 |
Why?
| | Biology | 1 | 2023 | 82 | 0.200 |
Why?
| | Interferons | 1 | 2024 | 187 | 0.200 |
Why?
| | Leukocytes | 1 | 2024 | 301 | 0.200 |
Why?
| | Flow Cytometry | 4 | 2019 | 1151 | 0.190 |
Why?
| | Disease Models, Animal | 4 | 2023 | 4016 | 0.190 |
Why?
| | Humans | 24 | 2024 | 129705 | 0.180 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2013 | 206 | 0.180 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 636 | 0.180 |
Why?
| | Arterial Pressure | 1 | 2021 | 119 | 0.170 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1423 | 0.170 |
Why?
| | Gene Expression | 2 | 2024 | 1477 | 0.170 |
Why?
| | Male | 14 | 2023 | 63544 | 0.160 |
Why?
| | Rats | 5 | 2013 | 5244 | 0.150 |
Why?
| | Prognosis | 2 | 2017 | 3801 | 0.150 |
Why?
| | Interferon-alpha | 1 | 2019 | 191 | 0.150 |
Why?
| | MicroRNAs | 2 | 2015 | 671 | 0.140 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 67 | 0.140 |
Why?
| | Animals | 13 | 2023 | 34733 | 0.140 |
Why?
| | TRPM Cation Channels | 1 | 2017 | 72 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2017 | 3363 | 0.130 |
Why?
| | Histone Deacetylases | 3 | 2013 | 211 | 0.130 |
Why?
| | Blood Flow Velocity | 1 | 2017 | 414 | 0.130 |
Why?
| | Hemodynamics | 1 | 2021 | 1097 | 0.130 |
Why?
| | Female | 11 | 2023 | 68561 | 0.130 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 237 | 0.130 |
Why?
| | Gene Expression Profiling | 3 | 2013 | 1696 | 0.120 |
Why?
| | Rats, Wistar | 2 | 2013 | 396 | 0.120 |
Why?
| | Adolescent | 4 | 2021 | 20355 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 274 | 0.120 |
Why?
| | Mutation | 4 | 2003 | 3674 | 0.120 |
Why?
| | Inflammation | 4 | 2017 | 2705 | 0.120 |
Why?
| | Cardiovascular System | 1 | 2017 | 138 | 0.120 |
Why?
| | Atrial Natriuretic Factor | 1 | 2015 | 56 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2013 | 2340 | 0.120 |
Why?
| | Breath Tests | 1 | 2015 | 94 | 0.120 |
Why?
| | Cause of Death | 1 | 2017 | 394 | 0.120 |
Why?
| | Heart Ventricles | 2 | 2017 | 779 | 0.120 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2015 | 102 | 0.120 |
Why?
| | Chemokine CCL2 | 2 | 2013 | 122 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 60 | 0.110 |
Why?
| | Fluorescent Antibody Technique | 2 | 2011 | 393 | 0.110 |
Why?
| | Phenotype | 4 | 2017 | 3063 | 0.110 |
Why?
| | Angiotensin II | 1 | 2013 | 92 | 0.110 |
Why?
| | Vascular Remodeling | 1 | 2015 | 186 | 0.110 |
Why?
| | Receptors, Growth Factor | 2 | 2003 | 55 | 0.100 |
Why?
| | Mice | 6 | 2023 | 16585 | 0.100 |
Why?
| | Hypoxia | 4 | 2013 | 1073 | 0.100 |
Why?
| | Adventitia | 1 | 2012 | 41 | 0.100 |
Why?
| | Metalloporphyrins | 1 | 2013 | 106 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 1047 | 0.100 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2012 | 9 | 0.100 |
Why?
| | Activating Transcription Factor 6 | 1 | 2012 | 16 | 0.100 |
Why?
| | Cardiac Catheterization | 2 | 2017 | 583 | 0.100 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2012 | 24 | 0.100 |
Why?
| | Echocardiography | 1 | 2015 | 635 | 0.100 |
Why?
| | Bronchi | 1 | 2013 | 253 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 828 | 0.100 |
Why?
| | Receptor, Endothelin B | 1 | 2012 | 55 | 0.100 |
Why?
| | Monocytes | 2 | 2012 | 554 | 0.100 |
Why?
| | Receptor, Endothelin A | 1 | 2012 | 62 | 0.100 |
Why?
| | Cell Movement | 2 | 2013 | 934 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 2 | 2002 | 49 | 0.090 |
Why?
| | Inflammasomes | 1 | 2013 | 128 | 0.090 |
Why?
| | Leukocyte Common Antigens | 1 | 2011 | 80 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 154 | 0.090 |
Why?
| | Chemokine CXCL12 | 1 | 2011 | 79 | 0.090 |
Why?
| | Fibrosis | 1 | 2013 | 521 | 0.090 |
Why?
| | Peptide Fragments | 1 | 2015 | 694 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 184 | 0.090 |
Why?
| | Cell Count | 1 | 2011 | 317 | 0.090 |
Why?
| | Immunomodulation | 1 | 2011 | 90 | 0.090 |
Why?
| | Transforming Growth Factor beta | 2 | 2004 | 462 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 504 | 0.090 |
Why?
| | Stem Cells | 2 | 2012 | 572 | 0.090 |
Why?
| | Vasodilator Agents | 1 | 2012 | 325 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2013 | 479 | 0.090 |
Why?
| | Cell Separation | 1 | 2011 | 313 | 0.080 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 754 | 0.080 |
Why?
| | Hyaluronic Acid | 1 | 2012 | 214 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2015 | 736 | 0.080 |
Why?
| | Ventricular Remodeling | 1 | 2012 | 255 | 0.080 |
Why?
| | Arrhythmias, Cardiac | 1 | 2011 | 312 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 730 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2272 | 0.070 |
Why?
| | Infant | 2 | 2012 | 9097 | 0.070 |
Why?
| | Autoimmunity | 1 | 2013 | 869 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1687 | 0.070 |
Why?
| | Signal Transduction | 3 | 2013 | 4863 | 0.070 |
Why?
| | Child, Preschool | 2 | 2012 | 10565 | 0.070 |
Why?
| | Epigenesis, Genetic | 1 | 2011 | 614 | 0.070 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2005 | 16 | 0.060 |
Why?
| | Pneumonia | 1 | 2011 | 613 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2539 | 0.060 |
Why?
| | Young Adult | 2 | 2011 | 12363 | 0.060 |
Why?
| | Angiopoietins | 1 | 2003 | 13 | 0.060 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 32 | 0.060 |
Why?
| | Transcription Factors | 1 | 2012 | 1636 | 0.050 |
Why?
| | Herpesvirus 8, Human | 1 | 2003 | 61 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3351 | 0.050 |
Why?
| | Risk Factors | 1 | 2017 | 9832 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2002 | 773 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 14 | 0.050 |
Why?
| | MutS Homolog 2 Protein | 1 | 2002 | 14 | 0.050 |
Why?
| | Herpesviridae Infections | 1 | 2003 | 142 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 63 | 0.050 |
Why?
| | Frameshift Mutation | 1 | 2002 | 32 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 126 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 828 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2017 | 5279 | 0.040 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2002 | 234 | 0.040 |
Why?
| | Cattle | 2 | 2013 | 971 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2001 | 391 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 802 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2001 | 929 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2012 | 10299 | 0.040 |
Why?
| | Adult | 4 | 2019 | 35595 | 0.040 |
Why?
| | Base Sequence | 1 | 2001 | 2161 | 0.030 |
Why?
| | Listeriosis | 1 | 2017 | 69 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2017 | 181 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 962 | 0.030 |
Why?
| | Listeria monocytogenes | 1 | 2017 | 124 | 0.030 |
Why?
| | Blotting, Western | 2 | 2011 | 1189 | 0.030 |
Why?
| | Apoptosis | 2 | 2002 | 2485 | 0.030 |
Why?
| | Cell Line | 1 | 2001 | 2768 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 579 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 588 | 0.030 |
Why?
| | Macrophages | 2 | 2012 | 1459 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1406 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 16 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 71 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 62 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 739 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 303 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 114 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 137 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 197 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 182 | 0.030 |
Why?
| | Vasa Vasorum | 1 | 2012 | 33 | 0.030 |
Why?
| | Caspase 1 | 1 | 2013 | 143 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2013 | 369 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 154 | 0.020 |
Why?
| | Connective Tissue | 1 | 2011 | 39 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2017 | 806 | 0.020 |
Why?
| | Interleukin-18 | 1 | 2013 | 239 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 191 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 581 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2778 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 329 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2013 | 376 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2011 | 178 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2011 | 452 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 463 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2012 | 413 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 31103 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2011 | 819 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4939 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 444 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 472 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2088 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1409 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2314 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1858 | 0.020 |
Why?
| | Prospective Studies | 1 | 2017 | 7130 | 0.020 |
Why?
| | Densitometry | 1 | 2005 | 32 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 25 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2005 | 55 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2005 | 210 | 0.010 |
Why?
| | Blood Pressure | 1 | 2012 | 1747 | 0.010 |
Why?
| | Epithelium | 1 | 2005 | 313 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors | 1 | 2003 | 6 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4058 | 0.010 |
Why?
| | Species Specificity | 1 | 2005 | 567 | 0.010 |
Why?
| | Genes, Viral | 1 | 2003 | 94 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2003 | 49 | 0.010 |
Why?
| | Cyclins | 1 | 2003 | 86 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 833 | 0.010 |
Why?
| | Down-Regulation | 1 | 2005 | 637 | 0.010 |
Why?
| | Arteries | 1 | 2004 | 268 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 76 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 850 | 0.010 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 109 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 120 | 0.010 |
Why?
| | DNA, Viral | 1 | 2003 | 381 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2005 | 493 | 0.010 |
Why?
| | Viral Proteins | 1 | 2003 | 330 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2003 | 784 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 530 | 0.010 |
Why?
| | RNA | 1 | 2001 | 877 | 0.010 |
Why?
|
|
Yeager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|